Sarepta Therapeutics total liabilities and share holders equity for the quarter ending September 30, 2024 was $3.600B, a 15.76% increase year-over-year.
Sarepta Therapeutics total liabilities and share holders equity for 2023 was $3.265B, a 4.35% increase from 2022.
Sarepta Therapeutics total liabilities and share holders equity for 2022 was $3.128B, a 0.62% decline from 2021.
Sarepta Therapeutics total liabilities and share holders equity for 2021 was $3.148B, a 5.47% increase from 2020.
Sarepta Therapeutics Total Liabilities and Share Holders Equity 2010-2024 | SRPT